ADIPOQ and metabolic dysfunction-associated steatohepatitis: A recent study analysing several of these mediators in patients with NASH versus controls showed decreased levels of adiponectin, increased levels of leptin and resisitin and unaltered levels of ghrelin in the NASH group.